Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly and Company $LLY Shares Purchased by Cyndeo Wealth Partners LLC
06:06am, Monday, 23'rd Mar 2026
Cyndeo Wealth Partners LLC boosted its stake in Eli Lilly and Company (NYSE: LLY) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Procyon Advisors LLC Has $7.77 Million Holdings in Eli Lilly and Company $LLY
05:24am, Monday, 23'rd Mar 2026
Procyon Advisors LLC increased its position in shares of Eli Lilly and Company (NYSE: LLY) by 176.8% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exch
The Best Stocks to Invest $1,000 in Right Now
04:44am, Monday, 23'rd Mar 2026
Google parent Alphabet is arguably the best all-around AI stock on the market. Chevron is an ideal stock with soaring oil prices but is also well-positioned for the long term.
QP Wealth Management LLC Purchases Shares of 706 Eli Lilly and Company $LLY
05:34am, Sunday, 22'nd Mar 2026
QP Wealth Management LLC acquired a new stake in shares of Eli Lilly and Company (NYSE: LLY) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange
Should You Buy Eli Lilly Stock Before April 10?
05:10am, Sunday, 22'nd Mar 2026
Eli Lilly dominates the U.S. weight loss drug market. The company's weight loss portfolio brought in more than $11 billion in the latest quarter.
Eli Lilly and Company $LLY Shares Sold by Covea Finance
05:00am, Sunday, 22'nd Mar 2026
Covea Finance cut its stake in Eli Lilly and Company (NYSE: LLY) by 22.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The
Is This Stock a Buy on the Dip?
06:30pm, Saturday, 21'st Mar 2026
Eli Lilly is well-positioned to maintain its lead in the anti-obesity market. The company's newer products in this niche will help expand its reach.
Our Top 10 High Growth Dividend Stocks - March 2026
08:15am, Saturday, 21'st Mar 2026
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat
Weekend Morning Brew: Oil Shock, Fed Hold, Nvidia GTC, Wegovy
07:37am, Saturday, 21'st Mar 2026
Weekly Market HighlightsMarket breadth was notably negative with 2,986 advancers versus 6,574 decliners, and the mean weekly return of 0.43% versus a median of
Foguth Wealth Management LLC. Makes New $734,000 Investment in Eli Lilly and Company $LLY
07:19am, Saturday, 21'st Mar 2026
Foguth Wealth Management LLC. bought a new position in shares of Eli Lilly and Company (NYSE: LLY) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The fu
GAMMA Investing LLC Raises Holdings in Eli Lilly and Company $LLY
07:19am, Saturday, 21'st Mar 2026
GAMMA Investing LLC increased its holdings in Eli Lilly and Company (NYSE: LLY) by 27.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The
Anderson Hoagland & Co. Has $22.12 Million Position in Eli Lilly and Company $LLY
06:44am, Saturday, 21'st Mar 2026
Anderson Hoagland and Co. trimmed its stake in Eli Lilly and Company (NYSE: LLY) by 8.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
LLY's Next-Gen Obesity Drug Meets Goal in First Phase III Study for T2D
04:21pm, Friday, 20'th Mar 2026
Eli Lilly reports strong Phase III results for retatrutide in type 2 diabetes, with significant A1C reduction and up to 16.8% weight loss in the latest study.
Why Eli Lilly Remains My Top Obesity Bet
01:38pm, Friday, 20'th Mar 2026
Despite HSBC downgrading Eli Lilly and Company stock, it remains my favorite in the obesity treatment market. That's also because LLY's tirzepatide franchise sales grew 114.6% year-on-year to about $1
My Top 3 Drug Stocks for March 2026
06:30am, Friday, 20'th Mar 2026
Innovative drugmakers tend to perform well over the long run. These three drug stocks can launch new products while maintaining or improving their financial results.
